In this work we have developed an analysis strategy to discover pathways downstream of FOXD1 that control the G2/M phase of the cell cycle in ccRCC using a 786-OFOXD1null ccRCC cell line. This evidence concerns the gene FOXD1 and nonpapillary renal cell carcinoma.